Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research
Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research have?
Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research has 26 citations in the OpenAlex counts ScholarIQ stores.
When was Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research published?
Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research has 2025 year in the ScholarIQ index.
What is the open-access status of Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research?
Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research has gold oa status in the ScholarIQ index.
What is the DOI of Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research?
The DOI for Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research is on the source record.
What is the PMID of Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research?
The PMID for Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research is on the source record.
What is the OpenAlex record for Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research?
The OpenAlex for Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research is on the source record.